State IA
Clinical Trials in Iowa
Recruiting clinical trials with at least one study location in Iowa. Data updated daily from ClinicalTrials.gov.
Top Conditions in Iowa
Chronic Lymphocytic Leukemia (4)Non-small Cell Lung Cancer (3)Stage IVB Prostate Cancer AJCC v8 (3)Small Lymphocytic Lymphoma (3)COVID-19 (3)Head and Neck Squamous Cell Carcinoma (2)Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)Stage II Lip and Oral Cavity Cancer AJCC v8 (2)Multiple Myeloma (2)Crohn's Disease (2)Stage IV Lung Cancer AJCC v8 (2)
Frequently Asked Questions — Clinical Trials in Iowa
How many clinical trials are currently recruiting in Iowa?
ClinicalMetric currently tracks 134 actively recruiting clinical trials with at least one location in Iowa. The total number of registered studies—including active but not currently enrolling trials—is 134. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Iowa?
Iowa hosts clinical trials across a broad range of medical conditions, including Chronic Lymphocytic Leukemia, Non-small Cell Lung Cancer, Stage IVB Prostate Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Iowa serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Iowa?
To join a clinical trial in Iowa, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Iowa maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Iowa
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT02915198 Phase 4
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuT...
Condition
Prediabetic State
Enrollment
7,410 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT04114084 N/A
Recruiting
Sleep Apnea in Patients With MGUS and MM
Condition
Multiple Myeloma
Enrollment
200 pts
Location
United States
Sponsor
Michael Tomasson
NCT07228117 N/A
Recruiting
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adult...
Condition
Type 1 Diabetes Mellitus
Enrollment
400 pts
Location
United States, Australia, New Zealand
Sponsor
Medtronic MiniMed, Inc.
NCT05719558 Phase 1
Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
210 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
NCT04661358 Phase 3
Recruiting
Fenofibrate for Prevention of DR Worsening
Condition
Diabetic Retinopathy
Enrollment
560 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT06249555 N/A
Recruiting
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With C...
Condition
Crohn's Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
Alimentiv Inc.
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT07173543 N/A
Recruiting
IH, Brain Health, and T2D
Condition
Type 2 Diabetes
Enrollment
80 pts
Location
United States
Sponsor
Darren P Casey
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06016946 N/A
Recruiting
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Condition
Friedreich Ataxia
Enrollment
3,000 pts
Location
United States, Australia, Austria
Sponsor
Friedreich's Ataxia Research A
NCT06143956 Phase 2
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices ...
Condition
Obesity
Enrollment
1,217 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
NCT06010329 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Loca...
Condition
Non-small Cell Lung Cancer
Enrollment
66 pts
Location
United States
Sponsor
Teligene US
NCT06165341 Phase 3
Recruiting
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alp...
Condition
Alpha1-Antitrypsin Deficiency
Enrollment
50 pts
Location
United States, Austria, Belgium
Sponsor
Takeda
NCT07225127 N/A
Recruiting
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder ...
Condition
Bladder Cancer
Enrollment
408 pts
Location
United States
Sponsor
University of Washington
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT06559969 Phase 2, Phase 3
Recruiting
IV vs Epidural Opioids + Epidural Local Anesthetic for Laparotomy Analgesia
Condition
Laparotomy
Enrollment
80 pts
Location
United States
Sponsor
University of Iowa
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT06552754 N/A
Recruiting
Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteer...
Condition
Healthy Volunteers
Enrollment
150 pts
Location
United States
Sponsor
National Human Genome Research
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT03999983 N/A
Recruiting
Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
Condition
Vertebral Artery Stenosis
Enrollment
150 pts
Location
United States
Sponsor
St. Louis University
NCT04064359 Phase 1
Recruiting
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid T...
Condition
Solid Tumor
Enrollment
200 pts
Location
United States, Belgium, France
Sponsor
Oxford BioTherapeutics Ltd
Page 1 of 6 — 134 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology